35423107|t|Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease.
35423107|a|Acetylcholinesterase (AChE) inhibitors such as donepezil, galantamine and rivastigmine are used for the management of dementia in Alzheimer's Disease (AD). These drugs elevate endogenous acetylcholine (ACh) levels at the M1 muscarinic receptor in the brain to achieve therapeutic benefits. However, their side effects, such as nausea, vomiting, dizziness, insomnia, loss of appetite, altered heart rate, etc., are related to non-specific peripheral activation of M2-M5 muscarinic subtypes. It is logical, therefore, to develop drugs that selectively activate brain M1 receptors. Unfortunately, the orthosteric site homology among the receptor subtypes does not permit this approach. An alternative approach is to use positive allosteric modulator (PAM) of M1 receptors like benzyl quinolone carboxylic acid (BQCA). PAMs although devoid of M1 agonist activity, however, when bound, enhance the binding affinity of orthosteric ligand, Ach. The current challenge with PAMS is their low brain half-life, permeability, and higher elimination rates. This study reports active targeting of brain M1 receptors using surface modified nano lipid-drug conjugates (LDC) of M1 PAM, BQCA, to treat AD. Polysorbate-80 (P-80) surface modified stearylamine (SA)-BQCA conjugated nanoparticles (BQCA-SA-P80-NPs) were prepared by conjugating BQCA to SA, followed by the formation of nanoparticles (NPs) using P-80 by solvent injection method. The BQCA-SA-P80-NPs are near-spherical with a particle size (PS) of 166.62 +- 1.24 nm and zeta potential (ZP) of 23.59 +- 0.37 mV. In the in vitro cytotoxicity (SH-SY5Y cells) and hemolysis assays, BQCA-SA-P80-NPs, show acceptable safety and compatibility. In mice, Alzheimer's model, BQCA-SA-P80-NPs significantly prevent STZ induced changes in memory, neuronal Abeta1-42, p-Tau, APP, NF-kappaB, and BACE levels and neuronal cell death, when compared to untreated disease control and naive BQCA treated group. Further, BQCA-SA-P80-NPs significantly improve the therapeutic efficacy of AChE inhibitor, donepezil (DPZ), indicating its potentiating effects. In vivo biodistribution studies in mice show selective accumulation of BQCA-SA-P80-NPs in the brain, suggesting an improved brain bioavailability and reduced peripheral side effects of BQCA. The study results demonstrate that BQCA-SA-P80-NPs can improve brain bioavailability and therapeutic efficacy of BQCA in AD.
35423107	0	14	Polysorbate-80	Chemical	MESH:D011136
35423107	37	49	stearylamine	Chemical	MESH:C009317
35423107	50	54	BQCA	Chemical	-
35423107	87	106	Alzheimer's disease	Disease	MESH:D000544
35423107	108	128	Acetylcholinesterase	Gene	43
35423107	130	134	AChE	Gene	43
35423107	155	164	donepezil	Chemical	MESH:D000077265
35423107	166	177	galantamine	Chemical	MESH:D005702
35423107	182	194	rivastigmine	Chemical	MESH:D000068836
35423107	226	234	dementia	Disease	MESH:D003704
35423107	238	257	Alzheimer's Disease	Disease	MESH:D000544
35423107	259	261	AD	Disease	MESH:D000544
35423107	295	308	acetylcholine	Chemical	MESH:D000109
35423107	310	313	ACh	Chemical	MESH:D000109
35423107	435	441	nausea	Disease	MESH:D009325
35423107	443	451	vomiting	Disease	MESH:D014839
35423107	453	462	dizziness	Disease	MESH:D004244
35423107	464	472	insomnia	Disease	MESH:D007319
35423107	474	490	loss of appetite	Disease	MESH:D001068
35423107	882	914	benzyl quinolone carboxylic acid	Chemical	-
35423107	916	920	BQCA	Chemical	-
35423107	1041	1044	Ach	Chemical	MESH:D000109
35423107	1073	1077	PAMS	Disease	
35423107	1238	1243	lipid	Chemical	MESH:D008055
35423107	1277	1281	BQCA	Chemical	-
35423107	1292	1294	AD	Disease	MESH:D000544
35423107	1296	1310	Polysorbate-80	Chemical	MESH:D011136
35423107	1312	1316	P-80	Chemical	MESH:D011136
35423107	1335	1347	stearylamine	Chemical	MESH:C009317
35423107	1349	1351	SA	Chemical	MESH:C009317
35423107	1353	1357	BQCA	Chemical	-
35423107	1384	1399	BQCA-SA-P80-NPs	Chemical	-
35423107	1430	1434	BQCA	Chemical	-
35423107	1438	1440	SA	Chemical	MESH:C009317
35423107	1497	1501	P-80	Chemical	MESH:D011136
35423107	1535	1550	BQCA-SA-P80-NPs	Chemical	-
35423107	1678	1690	cytotoxicity	Disease	MESH:D064420
35423107	1692	1699	SH-SY5Y	CellLine	CVCL:0019
35423107	1711	1720	hemolysis	Disease	MESH:D006461
35423107	1729	1744	BQCA-SA-P80-NPs	Chemical	-
35423107	1791	1795	mice	Species	10090
35423107	1797	1808	Alzheimer's	Disease	MESH:D000544
35423107	1816	1831	BQCA-SA-P80-NPs	Chemical	-
35423107	1854	1857	STZ	Chemical	MESH:D013311
35423107	1917	1926	NF-kappaB	Gene	18033
35423107	1932	1936	BACE	Gene	23821
35423107	1948	1967	neuronal cell death	Disease	MESH:D009410
35423107	2022	2026	BQCA	Chemical	-
35423107	2051	2066	BQCA-SA-P80-NPs	Chemical	-
35423107	2117	2121	AChE	Gene	11423
35423107	2133	2142	donepezil	Chemical	MESH:D000077265
35423107	2144	2147	DPZ	Chemical	MESH:D000077265
35423107	2222	2226	mice	Species	10090
35423107	2258	2273	BQCA-SA-P80-NPs	Chemical	-
35423107	2372	2376	BQCA	Chemical	-
35423107	2413	2428	BQCA-SA-P80-NPs	Chemical	-
35423107	2491	2495	BQCA	Chemical	-
35423107	2499	2501	AD	Disease	MESH:D000544
35423107	Negative_Correlation	MESH:D000068836	MESH:D000544
35423107	Negative_Correlation	MESH:D000077265	MESH:D000544
35423107	Negative_Correlation	MESH:D011136	MESH:D000544
35423107	Association	MESH:D013311	23821
35423107	Positive_Correlation	MESH:D000068836	MESH:D009325
35423107	Positive_Correlation	MESH:D013311	MESH:D009410
35423107	Negative_Correlation	MESH:D000077265	43
35423107	Negative_Correlation	MESH:D005702	MESH:D000544
35423107	Negative_Correlation	MESH:D000077265	MESH:D003704
35423107	Negative_Correlation	MESH:C009317	MESH:D000544
35423107	Positive_Correlation	MESH:D000068836	MESH:D007319
35423107	Positive_Correlation	MESH:D000068836	MESH:D004244
35423107	Positive_Correlation	MESH:D000077265	MESH:D004244
35423107	Negative_Correlation	MESH:D000068836	43
35423107	Positive_Correlation	MESH:D000068836	MESH:D000109
35423107	Association	MESH:D013311	18033
35423107	Negative_Correlation	MESH:D000068836	MESH:D003704
35423107	Comparison	MESH:C009317	MESH:D011136
35423107	Negative_Correlation	MESH:D005702	MESH:D003704
35423107	Positive_Correlation	MESH:D005702	MESH:D009325
35423107	Positive_Correlation	MESH:D000077265	MESH:D000109
35423107	Negative_Correlation	MESH:D005702	43
35423107	Positive_Correlation	MESH:D000109	MESH:D005702
35423107	Positive_Correlation	MESH:D005702	MESH:D014839
35423107	Positive_Correlation	MESH:D005702	MESH:D004244

